Jonathan A Chatzkel

Jonathan A Chatzkel, M.D.

Assistant Professor

Department: MD-HEMATOLOGY/ONCOLOGY
Business Phone: (352) 265-0725
Business Email: jonathanchatzkel@ufl.edu

About Jonathan A Chatzkel

Jonathan Chatzkel, MD is an assistant professor of medicine in the division of hematology and oncology at the University of Florida College of Medicine. Dr. Chatzkel attended the University of Pennsylvania where he graduated magna cum laude, receiving a Bachelors of Arts degree with honors in Economics. He completed his medical degree at the Perelman School of Medicine at the University of Pennsylvania, followed by an internal medicine residency at Washington University in St. Louis, MO and a hematology and oncology fellowship at the Moffitt Cancer Center in Tampa, FL. Dr. Chatzel’s clinical interests include the care of patients with genitourinary cancers, including cancers of the kidney, bladder, prostate, and testis. He believes strongly in delivering individualized care to each of his patients. Professional affiliations include the American Society of Clinical Oncology, or ASCO.

Accomplishments

Max Kade Fellow
2013 · American Austrian Foundation/ Max Kade Foundation

Board Certifications

  • Internal Medicine
    American Board of Internal Medicine
  • Medical License
    Florida Medical Association
  • Medical Oncology
    American Board of Internal Medicine

Clinical Profile

Specialties
  • Medicine
Subspecialties
  • Cancer
  • Hematology and Oncology
Areas of Interest
  • Bladder cancer
  • Kidney Cancer
  • Prostate cancer
  • Testicular cancer

Research Profile

Areas of Interest
  • Biomarkers Response to Radium-223
  • Cell Pathology
  • Prostate Cancer

Publications

2021
Immunotherapy Management in Special Cancer Patient Populations.
JCO oncology practice. 17(5):240-245 [DOI] 10.1200/OP.20.00996. [PMID] 33710933.
2019
Circulating tumor cells and γH2AX as biomarkers for responsiveness to radium-223 in advanced prostate cancer patients.
Future science OA. 6(1) [DOI] 10.2144/fsoa-2019-0092. [PMID] 31915536.
2017
Correlation of Ki-67 Proliferative Antigen Expression and Tumor Response to Induction Chemotherapy Containing Cell Cycle-Specific Agents in Head and Neck Squamous Cell Carcinoma.
Head and neck pathology. 11(3):338-345 [DOI] 10.1007/s12105-016-0775-9. [PMID] 28025779.
2014
Expiratory air trapping on thoracic computed tomography. A diagnostic subclassification.
Annals of the American Thoracic Society. 11(6):874-81 [DOI] 10.1513/AnnalsATS.201311-390OC. [PMID] 24956379.
2012
Red nucleus degeneration in hypertrophic olivary degeneration after pediatric posterior fossa tumor resection: use of susceptibility-weighted imaging (SWI).
Pediatric radiology. 42(4):481-5 [DOI] 10.1007/s00247-011-2330-x. [PMID] 22218736.
2010
Metronidazole-induced cerebellar toxicity.
Pediatric radiology. 40(8) [DOI] 10.1007/s00247-009-1453-9. [PMID] 19915830.

Grants

Dec 2020 ACTIVE
PARALLEL PHASE III RANDOMIZED TRIALS FOR HIGH RISK PROSTATE CANCER EVALUATING DE-INTENSIFICATION FOR LOWER GENOMIC RISK AND INTENSIFICATION OF CONCURRENT THERAPY FOR HIGHER GENOMIC RISK WITH RADIATION (PREDICT-RT*)
Role: Principal Investigator
Funding: NRG ONCOLOGY FOU via NATL INST OF HLTH NCI
Sep 2019 ACTIVE
A Phase 3 Randomized Study Comparing Perioperative Nivolumab vs. Observation in Patients with Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
Role: Principal Investigator
Funding: NRG ONCOLOGY FOU via NATL INST OF HLTH NCI
May 2019 ACTIVE
PD-INHIBITOR (NIVOLUMAB) AND IPILIMUMAB FOLLOWED BY NIVOLUMAB VS. VEGF TKI CABOZANTINIB WITH NIVOLUMAB: A PHASE III TRIAL IN METASTATIC UNTREATED RENAL CELL CANCER [PDIGREE]
Role: Principal Investigator
Funding: NRG ONCOLOGY FOU via NATL INST OF HLTH NCI
Mar 2019 ACTIVE
PHASE III RANDOMIZED ADJUVANT STUDY OF MK-3475 (PEMBROLIZUMAB) IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA (AMBASSADOR) VERSUS OBSERVATION
Role: Principal Investigator
Funding: ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY via NATL INST OF HLTH NCI

Education

Fellowship, Hematology – Oncology
2016-2019 · Moffitt Cancer Center
Residency, Internal Medicine
2013-2016 · Washington University, St. Louis
Medical School, Doctor of Medicine
2008-2013 · Perleman School of Medicine at the University of Pennsylvania
Honors Bachelors of Arts, Economics
2000-2004 · University of Pennsylvania

Contact Details

Phones:
Business:
(352) 265-0725
Emails: